Placebo NanoTab

DRUG2 trials

Sponsors

Talphera, Inc

Conditions

Acute PainPost Operative Pain

Phase 2

A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Elective Unilateral Total Knee Replacement

CompletedNCT00612534

Talphera, IncPost Operative Pain

Start: 2008-03-31End: 2008-10-31Updated: 2014-02-17

Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

CompletedNCT01710345

Talphera, IncAcute Pain

Start: 2012-10-31End: 2013-02-28Updated: 2015-01-26